Oral osmotisches Hydromorphon für die symptomatische Behandlung chronischer Osteoporose bedingter Schmerzen unter alltäglichen Routinebedingungen

Autor:	S. Hesselbarth, J. D. Ringe, T. Giesecke, N. Vehreschild
Rok vydání:	2010
Předmět:	Constipation Nausea business.industry Osteoporosis Chronic pain medicine.disease Hydromorphone Discontinuation Rheumatology Tolerability Anesthesia medicine medicine.symptom business Adverse effect medicine.drug
Zdroj:	Aktuelle Rheumatologie. 35:389-397
ISSN:	1438-9940 0341-051X
DOI:	10.1055/s-0030-1267193
Popis:	This prospective, non-interventional study (OROSANA4001) was conducted at 71 sites throughout Germany. 219 adults with chronic pain due to osteoporosis and a pain intensity ≥6 on a numerical rating scale (NRS 0-10) were documented. Pain relief was rated by the patients on a scale from 0% (no relief) to 100% (complete relief) and the interference of pain with general activity was assessed on a scale from 0 to 10. Furthermore, satisfaction with pain therapy (by patient and physician) and patient's capability of physical therapy were evaluated. Tolerability was assessed by documentation of adverse events and study discontinuation. Treatment with oral osmotic hydromorphone decreased all pain intensity ratings significantly from baseline to the last assessment (p
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a721ad0015d2f7d2e4fb72725ded9abf https://doi.org/10.1055/s-0030-1267193 Zobrazit plný text záznamu